Lobbying disclosures · Lobbying report
UNH: third_quarter 2026 lobbying report
General business issues; Pharmacy benefit manager issues; Medicare advantage; Issues relating to health insurance; General healthcare competition issues; H.R.4710/S.2420 - No Surprises Enforcement Act; Budget reconciliation.
Follow UNH- Became public
- Oct 20, 2026, 1:20 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 10:00 PM EST
Why this is connected
Exact legal-name match: UNITEDHEALTH GROUP INC (https://www.sec.gov/Archives/edgar/data/731766/).
Reported lobbying amounts
Income: $120,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/40e22b15-4378-4172-8c61-ed73032cf2f4/","filing_uuid":"40e22b15-4378-4172-8c61-ed73032cf2f4","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/40e22b15-4378-4172-8c61-ed73032cf2f4/print/","filing_document_content_type":"text/html","income":"120000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kirk Blalock","dt_posted":"2026-10-20T13:20:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1155 F Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401103500,"url":"https://lda.gov/api/v1/registrants/401103500/","house_registrant_id":null,"name":"FIERCE GOVERNMENT RELATIONS","description":"Government Relations and Consulting","address_1":"1155 F Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KIRK BLALOCK","contact_telephone":"+1 202-333-8667","dt_updated":"2026-07-27T14:28:37.503543-04:00"},"client":{"id":199144,"url":"https://lda.gov/api/v1/clients/199144/","client_id":292,"name":"UNITEDHEALTH GROUP, INC.","general_description":"Heath Care Services","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General business issues; Pharmacy benefit manager issues; Medicare advantage; Issues relating to health insurance; General healthcare competition issues; H.R.4710/S.2420 - No Surprises Enforcement Act; Budget reconciliation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62605,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":"KIRK","last_name":"BLALOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61343,"prefix":null,"prefix_display":null,"first_name":"KIRSTEN","nickname":null,"middle_name":null,"last_name":"CHADWICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62662,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"CHAPPELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61342,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"HULL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150286,"prefix":null,"prefix_display":null,"first_name":"PATRICK","nickname":null,"middle_name":null,"last_name":"CLIFTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152778,"prefix":"mr","prefix_display":"MR.","first_name":"JACOBUS","nickname":null,"middle_name":null,"last_name":"VREEBURG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153955,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in UNH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 13, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Sep 23, 2026 · disclosed Oct 13, 2026 · Joint
Committee overlap: Ways and MeansGot $26K from the company’s PAC - Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
Sold (partial) UnitedHealth Group UNH
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
Got $9K from the company’s PAC - Sep 25, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Sep 10, 2026 · disclosed Sep 25, 2026 · Joint
Committee overlap: Ways and MeansGot $26K from the company’s PAC - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
Traded 6 days before earnings - Jul 13, 2026$1K–$15K
Sen. John Boozman (R-AR)
$1K–$15K · Traded Jun 4, 2026 · disclosed Jul 13, 2026 · Joint
- Jul 9, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
Sold (partial) UnitedHealth Group UNH
$1K–$15K · Traded Jun 12, 2026 · disclosed Jul 9, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.